ANDA 202993, held by Par Pharm Inc. Dextromethorphan Hydrobromide;Quinidine Sulfate.
As of Nov 16, 2026, ANDA 202993 (Dextromethorphan Hydrobromide And Quinidine Sulfate), held by Par Pharm Inc, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 23, 2015 | Original application | Tentative approval | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dextromethorphan Hydrobromide And Quinidine Sulfate20MG;10MG ยท capsule;oral | Dextromethorphan Hydrobromide;Quinidine Sulfate | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters